DE1617319A1 - Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum - Google Patents

Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum

Info

Publication number
DE1617319A1
DE1617319A1 DE19511617319 DE1617319A DE1617319A1 DE 1617319 A1 DE1617319 A1 DE 1617319A1 DE 19511617319 DE19511617319 DE 19511617319 DE 1617319 A DE1617319 A DE 1617319A DE 1617319 A1 DE1617319 A1 DE 1617319A1
Authority
DE
Germany
Prior art keywords
serum
stable
hepatitis
production
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19511617319
Other languages
German (de)
English (en)
Other versions
DE1617319B2 (enExample
DE1617319C3 (enExample
Inventor
Dr-Chem Wolfgang Stephan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Serum Institut GmbH
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Priority to DE19511617319 priority Critical patent/DE1617319A1/de
Priority claimed from DE1966B0089704 external-priority patent/DE1617335B2/de
Publication of DE1617319A1 publication Critical patent/DE1617319A1/de
Publication of DE1617319B2 publication Critical patent/DE1617319B2/de
Application granted granted Critical
Publication of DE1617319C3 publication Critical patent/DE1617319C3/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19511617319 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum Granted DE1617319A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19511617319 DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19511617319 DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum
DEB0086560 1966-04-06
DE1966B0089704 DE1617335B2 (de) 1966-11-05 1966-11-05 Verfahren zur herstellung von lipoproteinfreiem, stabilem und sterilem serum
DEB0091011 1967-02-02

Publications (3)

Publication Number Publication Date
DE1617319A1 true DE1617319A1 (de) 1971-02-11
DE1617319B2 DE1617319B2 (enExample) 1973-09-13
DE1617319C3 DE1617319C3 (enExample) 1974-05-02

Family

ID=27430606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19511617319 Granted DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum

Country Status (1)

Country Link
DE (1) DE1617319A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019939A1 (en) * 1979-06-04 1980-12-10 E.I. Du Pont De Nemours And Company Serum and plasma clarification process
EP0679405A1 (de) * 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019939A1 (en) * 1979-06-04 1980-12-10 E.I. Du Pont De Nemours And Company Serum and plasma clarification process
EP0679405A1 (de) * 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen

Also Published As

Publication number Publication date
DE1617319B2 (enExample) 1973-09-13
DE1617319C3 (enExample) 1974-05-02

Similar Documents

Publication Publication Date Title
AT392905B (de) Verfahren zur behandlung eines blutgerinnungsfaktors viii-konzentrats
DE3880292T2 (de) Ausscheidung von prozesschemikalien aus biologischen gemischen mit halogenierten kohlenwasserstoffen.
EP0047462A2 (de) Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE69332087T2 (de) Verfahren zur erhöhung den stickoxidkonzentration im blut
DE3734923C1 (de) Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
DE68913422T2 (de) Entfernen von Verfahrenschemikalien aus labilen biologischen Gemischen durch hydrophobe Austauschchromatographie.
US3686395A (en) Process for preparation of storage stable hepatitis-free serum
DE68903558T2 (de) Verfahren zur inaktivierung von viren.
DE3733181C1 (de) Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates
EP0246439A1 (de) Steriles Plasmaaustauschmittel
DE1617735A1 (de) Verfahren zur Herstellung eines inaktivierten Schweinecholera-Impfstoffs
DE2636757C2 (de) Verfahren zum Aufkonzentrieren und Reinigen des Antihämophiliefaktors
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
EP0307002B1 (de) Verfahren zur Herstellung eines Antithrombin III-Konzentrates
DE3914869C1 (enExample)
DE3888571T2 (de) Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen.
EP0065256A2 (de) Verfahren zur Herstellung von und danach hergestelltes Plasminogen
DE1617319A1 (de) Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum
EP0212040B1 (de) Verfahren zur Herstellung von Präparationen auf Basis von Blutgerinnungsfaktoren
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
DE1907014A1 (de) Verfahren zur Trennung von Blutkomponenten,insbesondere von immunologisch aktiven Globulinen,von anderen Komponenten
DE3609431A1 (de) Verfahren zur herstellung eines den blutgerinnungsfaktor viii enthaltenden, sterilen praeparates
DE4039721A1 (de) Verfahren zur herstellung eines pasteurisierten und eisenfreien human-transferrins und seine verwendung
DE2327687A1 (de) Antiseptisches mittel
DE68913212T2 (de) Ein reines faktor i-protein und verfahren zur herstellung.

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8339 Ceased/non-payment of the annual fee